作者
Regis Peffault de Latour, Anne Bergeron, Etienne Lengline, Thibault Dupont, Armance Marchal, Lionel Galicier, Nathalie de Castro, Louise Bondeelle, Michael Darmon, Clairelyne Dupin, Guillaume Dumas, Pierre Leguen, Isabelle Madelaine, Sylvie Chevret, Jean-Michel Molina, Elie Azoulay, Veronique Fremeaux-Bacchi
发表日期
2020/12/12
期刊
Haematologica
卷号
105
期号
12
页码范围
2847
出版商
Ferrata Storti Foundation
简介
Since the report of the first cases in December 2019, infection with the severe acute respiratory coronavirus 2 (SARS-CoV-2) commonly referred as COVID-19 has become a worldwide pandemic. 1 In patients with COVID-19 infection, respiratory deterioration has been associated with not only increased viral loads in the lung but also with an inadequate and exaggerated immune response. 2 Preclinical data have demonstrated a role for complement activation in CoV-mediated disease. Gralinski et al., found activation of the complement system in a mouse model of CoV. 3 In some patients with COVID-19, significant deposits of terminal complement components C5b-9 (membrane attack complex), C4d, and mannose binding lectin (MBL)-associated serine protease 2 (MASP-2) have been found in the microvasculature of different organs, consistent with sustained, systemic activation of the lectin-complement pathway …
引用总数
2020202120222023202452416133
学术搜索中的文章